Impact of non-cardiovascular disease burden on thirty-day hospital readmission in heart failure patients by Kutyifa, Valentina et al.
Address for correspondence: Valentina Kutyifa, MD, PhD, Heart Research Follow-up Program, Cardiology Division,  
University of Rochester Medical Center, 265 Crittenden Blvd., PO Box 653, Rochester, NY 14642, USA, tel: 585-275-2676, 
fax: 585-273-5283, e-mail: Valentina.Kutyifa@heart.rochester.edu or valentina.heart@alumni.harvard.edu
Received: 1.03.2018 Accepted: 7.07.2018
691www.cardiologyjournal.org
CLINICAL CARDIOLOGY
Cardiology Journal 
2018, Vol. 25, No. 6, 691–700
DOI: 10.5603/CJ.2018.0147 
Copyright © 2018 Via Medica
ISSN 1897–5593ORIGINAL ARTICLE
Impact of non-cardiovascular disease burden  
on thirty-day hospital readmission  
in heart failure patients
Valentina Kutyifa, John Rice, Roy Jones, Andrew Mathias, Ayhan Yoruk,  
Katherine Vermilye, Brent Johnson, Robert Strawderman, Charles Lowenstein
University of Rochester Medical Center, Rochester, New York, United States
Abstract
Background: Little is known about the impact of non-cardiovascular disease (CVD) burden on 30- 
-day readmission in heart failure (HF) patients. The aim of the study was to assess the role of non-CVD 
burden on 30-day readmission in HF patients.
Methods: We analyzed the effect of non-CVD burden by frequency of ICD-9 code categories on readmis-
sions of patients discharged with a primary diagnosis of HF. We first modeled the probability of readmis-
sion within 30 days as a function of demographic and clinical covariates in a randomly selected training 
dataset of the total cohort. Variable selection was carried out using a bootstrap LASSO procedure with 
1000 bootstrap samples, the final model was tested on a validation dataset. Adjusted odds ratios and 
confidence intervals were reported in the validation dataset.
Results: There were a total of 6228 HF hospitalizations, 1523 (24%) with readmission within 30 days 
of discharge. The strongest predictor for 30-day readmissions was any hospital admission in the prior 
year (p < 0.001). Cardiovascular risk factors did not enter the final model. However, digestive system 
diseases increased the risk for readmission by 17% for each diagnosis (p = 0.046), while respiratory 
diseases and genitourinary diseases showed a trend toward a higher risk of readmission (p = 0.07 
and p = 0.09, respectively). Non-CVDs out-competed cardiovascular covariates previously reported to 
predict readmission.
Conclusions: In patients with HF hospitalization, prior admissions predicted 30-day readmission. 
Diseases of the digestive system also increase 30-day readmission rates. Assessment of non-CVD burden 
in HF patients could serve as an important risk marker for 30-day readmissions. (Cardiol J 2018; 25, 
6: 691–700)
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Introduction
Heart failure (HF) is a significant health issue 
affecting approximately 5.7 million adults in the 
United States with estimated annual costs of over 
$30 billion [1]. About one quarter of the patients 
discharged with a primary diagnosis of HF are 
readmitted within 30 days [2]. Hospital readmis-
sions are associated with significant additional 
cost and adverse clinical outcomes. The Center for 
Medicare and Medicaid Services (CMS) Hospital 
Readmissions Reduction Program provides finan-
cial incentives to hospitals to reduce readmissions 
for these patients. As a result, significant attention 
and effort has been put in to reducing readmission 
of HF patients. 
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Identifying HF patients at high risk for hospital 
readmission is crucial for targeting interventions 
to reduce readmissions. Several prior studies pre-
dicted 30-day readmissions, although the predictive 
accuracy of these models is limited [3, 4]. Since 
the outcome of interest is 30-day readmission for 
any cause, it is possible that non-cardiovascular 
risk factors play an important role. While prior 
studies looked at socioeconomic and psychosocial 
characteristics [5], there is limited information on 
non-cardiovascular risk factors predicting 30-day 
readmission.
Therefore, in the present study, we aimed to 
develop a predictive model for HF readmissions 
including parameters reflecting non-cardiovascular 
disease (CVD) burden, using a novel statistical 
bootstrap LASSO approach for variable selection. 
In addition, we examined the specific reasons, 
including non-cardiovascular diagnoses, for which 
HF patients are readmitted within 30 days follow-
ing HF hospitalization discharge.
Methods
This is a retrospective analysis of hospital 
admission data for patients discharged from the 
University of Rochester Medical Center (Roch-
ester, NY) with a primary diagnosis of HF (ICD-9 
codes starting with 428, plus 402.01, 402.11, 
402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 
404.93). Patients under the age of 18 and patients 
that passed away before discharge were excluded 
from this study. 
Definitions and end points
An index admission for each patient was 
defined as an admission with a primary discharge 
diagnosis of HF between January 1st, 2007, and 
June 30th, 2014, as previously described [6]. Recur-
rent readmissions beyond the 30-day readmission 
window were included in the analysis. The primary 
outcome was 30-day hospital readmission for any 
cause, defined as a hospitalization for any cause 
within 30 days after discharge from the index 
HF admission. Records on hospital admissions 
between January 1st, 2006 and December 31, 2006 
were used to derive the number of hospital admis-
sions in the prior year for patients discharged in 
2007. 
When assessing the ability of non-cardiovascu-
lar diagnoses at the time of HF admission to predict 
subsequent readmissions, we used the following 
ICD-9 code categories: 1) infectious and parasitic 
diseases, 2) neoplasms, 3) endocrine, nutritional 
and metabolic diseases, and immunity disorders, 
4) diseases of the blood and blood-forming organs, 
5) mental disorders, 6) diseases of the nervous 
system, 7) diseases of the respiratory system, 
8) diseases of the digestive system, 9) diseases of 
the genitourinary system, 10) diseases of the skin 
and subcutaneous tissue, and 11) diseases of the 
musculoskeletal system and connective tissue. We 
assessed the total number of each diagnosis for 
a patient within these categories at the time of 
the index HF discharge as a covariate to predict 
30-day readmission. Specific reasons for readmis-
sions within 30 days following the HF index ad-
mission were also analyzed using the same ICD-9 
categories (< 1% was labeled “Other”).
Statistical analysis
Statistical analyses were performed using the 
R software [7]. The summary statistics in Tables 1 
and 2 were calculated using the entire data set of 
6228 HF hospitalizations. The significance tests 
and p-values for these tables were calculated us-
ing the generalized estimating equations (GEE) 
methodology [8], which takes into account the cor-
relation between multiple admissions for a single 
patient. For each covariate, a logistic regression 
GEE model was fit to the outcome containing that 
covariate only: the p-value displayed in the tables 
is for the robust test of no effect for that covariate 
on probability of 30-day readmission.
For the purposes of multivariate analyses, the 
data was first randomly split on the basis of patient 
ID into training and validation sets: the training 
set was used for purposes of model selection, 
while the validation set was used for calculation 
of coefficient estimates and standard errors for 
the selected model. We used multivariable GEE 
regression models to estimate the probability of 
30-day readmission. Our final model, with three 
standard CMS covariates (age, gender, and race) 
is shown in Table 3. For comparison, the same 
model without the three CMS covariates is shown 
in Table 4.
Variable selection was carried out using a boot-
strap LASSO procedure: 1000 bootstrap samples 
were generated from the training set, sampling 
with replacement on the basis of patients’ ID 
(repeated measurements on a subject were either 
all included or all excluded from each sample) [9]. 
For each of these samples, the LASSO procedure 
[10] was applied using the R package glmnet. The 
order in which the covariates entered the model 
was then recorded, with the covariate entering first 
considered to be the most predictive. Figure 1A 
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Table 1. Characteristics of patients and admissions by 30-day hospital readmission.
Parameters All  
admissions
Admissions 
with 30-day  
readmission
Admissions 
without 30-day 
readmission
P
Number of patients 1999 366 1633
Age [years]** 68.34 (15.5) 68.08 (16.1) 68.41 (15.4) 0.606
Female gender** 1668 (0.41) 346 (0.44) 1322 (0.40) 0.103
White race** 3063 (0.75) 582 (0.73) 2481 (0.76) 0.139
Number of admissions in prior year* 1.48 (2.36) 2.51 (3.48) 1.14 (1.73) < 0.001
Diagnoses on admission* 16.52 (6.4) 18.14 (6.88) 16.00 (6.14) < 0.001
Admission type emergency 4326 (0.69) 1144 (0.75) 3182 (0.68) < 0.001
Length of stay [days]* 8.99 (17.98) 11.01 (21.03) 8.34 (16.82) < 0.001
Disposition to home 5192 (0.83) 1205 (0.79) 3987 (0.85) < 0.001
Cardiovascular disease burden of admission
Hypertension 2069 (0.33) 440 (0.29) 1629 (0.35) < 0.001
Hyperlipidemia 2567 (0.41) 613 (0.40) 1954 (0.42) 0.407
Cardiomyopathy 1498 (0.24) 343 (0.23) 1155 (0.25) 0.206
Left bundle branch block 369 (0.06) 62 (0.04) 307 (0.07) < 0.001
Arrhythmias 302 (0.05) 55 (0.04) 247 (0.05) 0.009
Atrial fibrillation 2511 (0.40) 619 (0.41) 1892 (0.4) 0.798
Smoking 2179 (0.35) 533 (0.35) 1646 (0.35) 0.993
End stage renal disease 478 (0.08) 155 (0.10) 323 (0.07) < 0.001
Results are shown as count (proportion), except those with a * are mean (standard deviation). **Data are for all patients included, not for  
admissions.
Table 2. Non-cardiovascular disease burden of admissions by 30-day hospital readmission.
Parameters All  
admissions
Admissions 
with 30-day  
readmission
Admissions 
without 30-day  
readmission
P
Number of patients 1999 366 1633
Infectious and parasitic diseases 959 (0.15) 306 (0.20) 653 (0.14) < 0.001
Neoplasms 329 (0.05) 97 (0.06) 232 (0.05) 0.036
Endocrine, nutritional and metabolic diseases, 
and immunity disorders
5413 (0.87) 1354 (0.89) 4059 (0.86) 0.012
Diseases of the blood and blood-forming organs 2272 (0.36) 654 (0.43) 1618 (0.34) < 0.001
Mental disorders 2766 (0.44) 748 (0.49) 2018 (0.43) < 0.001
Diseases of the nervous system 2051 (0.33) 524 (0.34) 1527 (0.32) 0.196
Diseases of the respiratory system 2988 (0.48) 841 (0.55) 2147 (0.46) < 0.001
Diseases of the digestive system 2441 (0.39) 671 (0.44) 1770 (0.38) < 0.001
Diseases of the genitourinary system 4031 (0.65) 1134 (0.74) 2897 (0.62) < 0.001
Diseases of the skin and subcutaneous tissue 610 (0.10) 175 (0.11) 435 (0.09) 0.014
Diseases of the musculoskeletal system and 
connective tissue 
1352 (0.22) 342 (0.22) 1010 (0.21) 0.444
Results are shown as counts (proportions) of admissions for which any diagnoses in that category were present on admission.
shows boxplots depicting the distribution of vari-
able importance determined by this method, where 
variables are ordered from top to bottom by the 
mean order of entry. Also computed for each boot-
strap sample was the out-of-bag (OOB: all subjects 
in the training set not included in that particular 
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bootstrap sample) area under the ROC curve 
(AUC) [11] as a function of degrees of freedom 
in the model (Fig. 1B). The degrees of freedom 
reflect the number of covariates included and is 
a measure of model complexity. By using the 
OOB subjects to calculate AUC, we are able to get 
a more unbiased estimate than would be obtained 
from using the data twice (first to fit the model 
and then to compute AUC). The point at which the 
OOB AUC was maximized was used to determine 
an approximate number of covariates that should 
be included in the model. Suppose this criterion 
indicates that using d covariates is best; then, to 
construct our final model, we select the d covari-
ates that had the lowest average rank of entry into 
the LASSO model (i.e., at the top of Fig. 1A), where 
the average is calculated for each covariate over 
all bootstrap samples.
To obtain a predicted probability of readmis-
sion for each patient, we used the model selected 
by the bootstrap LASSO method on the training 
set, along with the standard CMS covariates, with 
coefficients estimated by applying that model to 
the training set. These estimated coefficients 
were then used to produce predictions for both the 
training and validation sets. The 95% confidence 
intervals were obtained by running an intercept-
only GEE model for each quantile separately under 
working independence correlation structure and 
applying the expit transform to the endpoints of 
a 95% confidence interval for the estimated logit 
of the mean (Fig. 2). We also assessed reason for 
readmission in the study by looking at the record 
for the next admission for hospitalizations that led 
to a 30-day readmission (Table 5). The table shows 
the count and percentage of admissions for each 
Table 3. Predictors of 30-day hospital readmission in a multivariate logistic regression model in the 
validation dataset.    
Covariate Estimate 95% LCL 95% UCL P
Number prior admissions (past year) 1.21 1.14 1.27 < 0.001
Log length of stay 1.14 1.00 1.30 0.057
Emergency admission 0.93 0.70 1.25 0.640
Discharge to home 0.78 0.57 1.08 0.132
Number of respiratory disease diagnoses 1.14 0.99 1.31 0.070
Number of digestive disease diagnoses 1.17 1.00 1.36 0.046
Number of genitourinary disease diagnoses 1.11 0.98 1.26 0.092
Age 0.99 0.99 1.00 0.173
Female gender 1.00 0.78 1.28 0.991
White race 0.91 0.69 1.20 0.504 
Area under the ROC curve (AUC): 0.643; LCL — lower confidence limit; UCL — upper confidence limit
Table 4. Predictors of 30-day hospital readmission in a multivariate logistic regression model in the 
validation dataset without Center for Medicare and Medicaid Services (CMS) covariates (age, gender, 
and race).
Covariate Estimate 95% LCL 95% UCL P
Log length of stay 1.15 1.01 1.315 0.033
Number prior admissions (past year) 1.22 1.16 1.285 < 0.001
Emergency admission 0.92 0.70 1.208 0.551
Discharge to home 0.84 0.61 1.142 0.263
Number of respiratory disease diagnoses 1.13 0.98 1.304 0.085
Number of digestive disease diagnoses 1.16 0.99 1.349 0.054
Number of genitourinary disease diagnoses 1.10 0.97 1.234 0.137
Area under the ROC curve (AUC): 0.642; LCL — lower confidence limit; UCL — upper confidence limit
Figure 1. A. Order of entry into the LASSO model in the training dataset. Panel A shows the distribution of order of en-
try into the LASSO model across 1000 bootstrap samples. Each boxplot corresponds to a covariate, which have been 
sorted for this figure by mean rank, so that the covariate appearing at the top would have, on average, entered the 
model earliest, etc; B. selection of covariates in the final model in the validation dataset. Panel B. shows the model’s 
predictive accuracy as a function of the degrees of freedom, or the number of variables included in the model. This 
is obtained for each bootstrap sample by predicting the outcomes for those hospitalizations that were not included 
in the fitting procedure for that sample (the out-of-bag, or OOB, sample), then computing the area under the ROC 
curve (AUC) for each value of the LASSO tuning parameter. This produces a curve of the type shown in this figure 
for each bootstrap sample. This figure was obtained by averaging the values of these curves at each point. The 95% 
confidence limits are obtained from the 0.025 and 0.975 quantiles of these curves at each point. The point at which 
the AUC is maximized gives an idea of a reasonable choice for the number of covariates to include in the final model; 
CI — confidence interval
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a total of 4061 unique patients (Fig. 3). There were 
a total of 1523 (24%) of these HF discharges that 
led to a subsequent readmission within 30 days.
Baseline clinical characteristics
Baseline characteristics of the 4061 patients’ 
age, gender, and race and other characteristics 
of the 6228 total HF discharges are displayed in 
Tables 1 and 2. The mean age of the study population 
was 68 years. Women made up 41% of the sample; 
75% were white. The mean length of stay was 
9 days. Patients with 30-day readmission were more 
often admitted to the emergency room (p < 0.001), 
ICD-9 code category of the primary diagnosis on 
readmission.
Results
There were 6652 hospital discharges with 
a primary diagnosis of HF between January 1st, 
2007, and June 30th, 2014, at the University of 
Rochester Medical Center. A total of 32 patients 
who were younger than 18 years were excluded 
from the analysis. In the remaining cohort of 6620 
hospitalizations, 392 patients died in the hospital, 
leaving us with 6228 total HF discharges from 
Figure 2. Calibration plot of the estimation of 30-day readmission rates in the training and validation datasets. This 
figure shows a calibration plot for the final selected model (shown in Table 4). This is obtained by first splitting the 
data along quantiles of the estimated risk of readmission separately for the training and validation data sets. For each 
such subgroup, the empirical mean of the outcome (open symbols) and the mean of the predicted probabilities (filled 
symbols) were calculated. Also shown are 95% binomial confidence intervals for the empirical outcome means.
Table 5. Specific reasons for readmission within 30 days in the total cohort by ICD-9 codes. 
Diagnosis Number  
of readmissions
Percentage  
(%)
Diseases of the circulatory system 883 58.0%
Diseases of the respiratory system 106 7.0%
Diseases of the genitourinary system 83 5.4%
Injury and poisoning 82 5.4%
Diseases of the digestive system 79 5.2%
Symptoms, signs, and ill-defined conditions 59 3.9%
Endocrine, nutritional and metabolic diseases, and immunity disorders 54 3.5%
External causes of injury and supplemental classification 54 3.5%
Infectious and parasitic diseases 50 3.3%
Diseases of the mental system 16 1.1%
Other 57 3.7%
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they had a longer length of stay (11 vs. 8 days, 
p < 0.001), and they were less likely to be discharged 
to home (p < 0.001). Hypertension (p < 0.001), left 
bundle branch block (p < 0.001), and arrhythmias 
(p < 0.01) were less prevalent in patients with 
readmissions, while end stage renal disease was 
more common in readmitted patients (p = 0.001).
We observed a high prevalence of non-CVD 
burden in our HF cohort. Table 2 displays the 
non-CVD burden of the 6228 HF discharges in our 
study. Over 80% of the admissions had additional 
diagnoses of endocrine, nutritional, metabolic or 
immunity disorders, and 65% of the admissions 
mentioned diseases of the genitourinary system. 
Other common diagnoses included respiratory 
disease (48%), mental disorders (44%), digestive 
disease (39%), diseases of the blood (36%), and 
diseases of the nervous system (33%). HF admis-
sions linked to subsequent 30-day readmission 
were more often accompanied with concomitant 
infectious diseases, diseases of the blood, mental 
disorders, and respiratory, digestive, and genitou-
rinary ailments (p < 0.001 for all). 
Predictors of 30-day readmissions  
in the training set
Using the LASSO procedure in our training 
set, the number of hospital admissions in the prior 
year (in the 365 days prior to the index admission) 
emerged as the strongest predictor of 30-day re-
admissions, followed by log length of stay and the 
number of concomitant genitourinary conditions 
at admission. Other relevant predictors were the 
number of respiratory conditions, the number of 
digestive disorders, emergency admission, and 
discharge to home (Fig. 1A). These covariates were 
similarly predictive of the end point in univariate 
analysis (Tables 1, 2). Using OOB AUC (averaged 
across all bootstrap samples) as a criterion, we de-
termined that our model should include these sev-
en covariates (i.e., appearing at the top of Fig. 1A), 
along with the three standard CMS covariates. In-
terestingly, no cardiovascular diagnoses and none 
of the CMS variables were among the seven most 
predictive covariates. 
Predictors of 30-day readmissions  
in the validation set
In our validation set (Table 3), one additional 
hospital admission in the prior year was associated 
with a 21% increase in the risk of 30-day readmis-
sion (p < 0.001; Fig. 4A), and each digestive system 
diagnosis increased the risk for readmission by 
17% (p < 0.05). Log-transformed length of stay 
(p < 0.06) showed a trend toward a higher risk of 
readmission, with longer stays being associated 
with greater risk of readmission. Respiratory and 
digestive diseases were similarly associated with 
higher risk or readmission with increasing burden 
of these co-morbidities (p = 0.07 and p = 0.09, 
respectively; Fig. 4B). Emergency admission and 
discharge to home performed less strongly in pre-
dicting 30-day readmission in the validation set. 
Removing the CMS covariates from our model led 
to only a very small reduction in AUC (AUC 0.643 
with CMS covariates, AUC 0.642 without CMS 
covariates; Table 4). The model including only CMS 
covariates had a substantially lower AUC of 0.542. 
A calibration plot estimating 30-day readmis-
sion rates in the training and validation set is dis-
played in Figure 2. This figure shows, for both the 
training and the validation sets, the average pre-
dicted probability of readmission within 30 days and 
the empirical proportion of 30-day readmissions, 
stratified by quantiles of the predicted risk of read-
mission. We see good general agreement between 
both observed and predicted risks and between 
the training and test sets, with three exceptions. 
At the 0.35 and 0.70 quantiles, the test set shows 
some underestimation of the risk of readmission 
(although the training set does not); at the highest 
end of the risk spectrum, risk seems to be over-
estimated by the model, both in the training and 
the test sets. There is also a gradual trend in the 
Figure 3. Study flowchart.
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means of the predicted probabilities where those 
of the training set are greater than those in the 
test set, with the difference increasing for higher 
quantiles of risk. A similar calibration plot using 
only the CMS covariates shows good agreement 
however the overall risk profile is much flatter 
in comparison to that seen in Figure 2, and also 
demonstrates comparatively poor agreement with 
the observed risk of readmission (data not shown). 
Cause-specific 30-day readmissions
Assessing specific reasons for 30-day readmis-
sion, we found that over half of the readmissions 
(58%) were due to diseases of the circulatory 
system, primarily due to HF. However, a signifi-
cant proportion of patients were admitted due to 
non-circulatory conditions, including respiratory 
disease (7%), such as pneumonia, bronchitis, or 
acute respiratory failure, genitourinary diseases 
(5%), such as kidney failure, injuries (5%), and 
diseases of the digestive system (5%) (Table 5).
Discussion
In the present study, we used a novel statistical 
method to derive and rank importance of predic-
tors of 30-day hospital readmission in patients 
hospitalized for HF in a training set that was tested 
in an independent validation set. Prior hospital 
admission emerged as a significant predictor of 
30-day hospital readmission. Importantly, non-
cardiovascular comorbidities played a role predict-
ing 30-day readmissions, including diseases of the 
digestive system, and diseases of the respiratory 
and genitourinary system. These data suggest the 
importance of diverse risk assessment of patients 
with HF admission including the assessment of 
non-cardiovascular risk factors. Confirming our 
observations, we also revealed that 30-day read-
missions often occurred due to non-cardiovascular 
causes. Assessment and proper management of 
non-cardiovascular co-morbidities could potentially 
reduce 30-day hospital readmissions.    
Our findings are novel and add to the estima-
tion of readmission risk by taking into account 
non-CVD burden. Interestingly, in our model, 
which included length of stay and prior hospital 
admissions, non-cardiovascular comorbidities 
out-competed other covariates such as that race, 
gender, and age, that had been previously reported 
to be important in predicting readmission [12]. 
A major reason why non-cardiovascular comorbidities 
Figure 4. The rate of 30-day readmission by A. Prior admissions; B. Number of respiratory diagnoses, number of 
digestive diagnoses, and number of genitourinary diagnoses. These figures display bar plots of the 30-day readmis-
sion rate within subgroups of the study population defined by some covariates. This rate is calculated as the sample 
mean of the binary outcome variable within each subgroup.
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predict hospital readmission is that a large percent-
age of patients who were originally hospitalized for 
HF are readmitted to the hospital for other reasons. 
This has previously been suggested by Krumholz 
et al. [13] using the National Medicare, and Davis 
et al. [14] in the Healthcare Cost and Utilization 
Project State Inpatient Databases. Our results 
are confirmatory, 42% of the readmissions were 
due to non-cardiovascular causes. Our study has 
important clinical relevance, identifying and prop-
erly managing non-CVD burden could potentially 
reduce readmissions and related healthcare costs 
and avoiding adverse outcomes [15–17]. 
Several studies suggested that atrial fibrilla-
tion and hypertension could be associated with the 
risk of hospital readmission [18, 19]. However, we 
found that patients with hypertension were less 
likely to be readmitted than those without. This 
could be explained by the fact that our center is 
a tertiary referral hospital and treats a dispropor-
tionately high percentage of advanced HF patients 
who are unlikely to have hypertension due to severe 
systolic dysfunction. It could be that patients with 
hypertension more often have with diastolic HF and 
those patients typically have worse outcomes due 
to the limited available treatment options [20, 21].
In our study, diseases of the digestive system, 
as well as respiratory and genitourinary diseases, 
were identified as predictors of 30-day hospital 
readmissions. Structural and functional changes to 
the gastrointestinal system are closely related to 
the process of HF, with intricate pathophysiology 
often blurring the line between primary and sec-
ondary events. Also, it is has been shown that HF-
-related congestion of the gastrointestinal system 
can lead to further HF exacerbation events through 
potential medication malabsorption [22, 23]. The 
impact of genitourinary disease including renal 
dysfunction on the progression of HF has been 
well described in the literature [24, 25]. Patients 
with renal dysfunction are at risk for accelerated 
atherosclerosis, hypertension, and fluid retention, 
all of which have unfavorable consequences for 
HF patients. Furthermore, these patients are less 
likely to be on guideline directed optimal medical 
therapy for systolic dysfunction due to concern for 
exacerbation of renal function or the development 
of hyperkalemia. Finally, cardiorenal syndrome 
has been described as a separate entity in HF pa-
tients, associated with adverse clinical outcomes 
[26]. However, our study has not been designed 
to specifically prove causality between these non-
-cardiovascular disorders and readmissions, and 
further studies are warranted.
Despite the inclusion of non-cardiovascular 
factors, our predictive model is still insufficient 
to explain a significant proportion of readmis-
sions. This is similar to prior predictive models 
[27–29], despite including information on mental 
health, cognitive function, or socioeconomic fac-
tors [30–33]. We have to acknowledge that 30-day 
readmissions are complex, multifaceted events that 
might include post-hospital syndrome [34, 35], or 
frailty [36].
Our study has limitations. First, this is 
a single-center study, and therefore, the results may 
not be generalizable. Our study is retrospective 
and non-randomized, and might carry referral bias, 
selection bias and confounding. Lack of follow-up 
for patients who died within 30 days or who were 
readmitted to another hospital system may have 
affected our analysis. 
Conclusions
In a single-center analysis of 30-day readmis-
sions following hospitalization for HF, digestive 
disorders along with prior admissions were predic-
tive of 30-day readmission, while diseases of the 
respiratory and genitourinary system, and length 
of stay showed a trend for association. More than 
40% of readmissions in our cohort were due to non-
cardiovascular diagnoses. Our study highlights the 
need for assessment of non-CVD burden when es-
timating 30-day readmission risk in HF patients, as 
well as identifying preventive measures targeting 
non-CVD burden to reduce 30-day readmissions.
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